Expression of thimet oligopeptidase (THOP) modulated by oxidative stress in human multidrug resistant (MDR) leukemia cells
Abstract
No abstract availableKeywords
Funding Information
- CNPq (423165/2021-6)
- FAPESP (2017/04352-0, 2018/09158-0, 2019/01487-7)
This publication has 66 references indexed in Scilit:
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor CellsJNCI: Journal of the National Cancer Institute, 2013
- P-glycoprotein Inhibition for Optimal Drug DeliveryDrug Target Insights, 2013
- The P-glycoprotein multidrug transporterEssays in Biochemistry, 2011
- Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myelomaBlood, 2010
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR ExperimentsClinical Chemistry, 2009
- In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarrayLeukemia, 2009
- Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growthMolecular Cancer, 2007
- Mechanisms of immune evasion of human neuroblastomaCancer Letters, 2005
- Thimet Oligopeptidase (EC 3.4.24.15), a Novel Protein on the Route of MHC Class I Antigen PresentationBiochemical and Biophysical Research Communications, 1999
- Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporterNature, 1991